Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma.

CONCLUSIONS: Down-regulation of FSTL5 may contribute to EMT of HCC, and FSTL5 is a potential target in the treatment of HCC.
PMID: 32740091 [PubMed - in process]

Source: Chinese Medical Journal - August 4, 2020 Category: General Medicine Authors: Zhang DY, Lei JS, Sun WL, Wang DD, Lu Z Tags: Chin Med J (Engl) Source Type: research